More articles from Oncology, Basic and Translational (Basic Science) I

You have access
Dynamic PET/CT imaging of ¹⁸F-(2S, 4R)4-fluoroglutamine in healthy volunteers and oncological patients
Xiaoxia Xu, Hua Zhu, Hank Kung and Zhi Yang

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 206;
You have access
A PET imaging strategy to quantify the residence time and kinetics of antibody therapeutics at the tumor
Dhiraj Kumar, Ala Lisok, Sagar Shelake, Martin Pomper and Sridhar Nimmagadda

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 211;
You have access
A preliminary study on the impact of fever on the biodistribution of 18F-FDG in vivo
Yao yutang and Cheng Zhuzhong

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 209;
You have access
Adjuvant intraperitoneal radioimmunotherapy with ⁶⁴Cu-cetuximab extends postsurgical survival by attenuating recurrences in a clinically-relevant orthotopic pancreatic cancer xenograft model
Yukie Yoshii, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, Ming-Rong Zhang, Kotaro Nagatsu, Aya Sugyo, Atsushi Tsuji and Tatsuya Higashi

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 210;
You have access
Preclinical development and First-in-human imaging of 89Zr-Daratumumab for CD38 targeted imaging of myeloma
Gary Ulaner, Nicholas Sobol, Joseph O'Donoghue, Eva Burnazi, Kevin Staton, Wolfgang Weber, Serge Lyashchenko, Jason Lewis and C. Ola Landgren

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 203;
You have access
Noninvasive Differentiation of Glioblastoma Multiforme (GBM) EGFR-Variants Using PET Imaging with ¹¹C-Glutamine
Su-Tang Lo, Guo Gao, Khaled Nasr, Kien Nham, Nicklas Rydberg, Amyn Habib and Xiankai Sun

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 207;
You have access
(4S)-4-(3-¹⁸F-fluoropropyl)-L-Glutamate (FSPG), ¹⁸F-fluoroestradiol (FES), and ¹⁸F-flurodeoxyglucose (FDG) PET/CT in Phenotyping Patients with Hormone Refractory Breast Cancer
Mei-Fang Cheng, CHEN Wei-Wu, Ya-Yao Huang, Yu-Wen TIEN, Chia-Ju Liu, Yen-Shen LU and Rouh-Fang Yen

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 205;
You have access
A Novel Theranostic Trial Design Using ⁶⁴Cu/⁶7Cu with Fully 3D Pre-Treatment Dosimetry
Dale Bailey, Geoff Schembri, Kathy Willowson, Amos Hedt, Eva Lengyelova and Matt Harris

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 204;
You have access
Theranostics of osteosarcoma and lung metastasis with new^{integrinα_vβ₃ receptor targeted radiotracers}
Guoqiang Shao, Jisheng Sui, Pengjun Zhang and Lulu Zhang

Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 208;

Main menu

User menu

Search

More articles from Oncology, Basic and Translational (Basic Science) I